Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Treasury Shares (2019 - 2022)

Serina Therapeutics (SER) has disclosed Treasury Shares for 4 consecutive years, with $3000.0 as the latest value for Q4 2022.

  • Quarterly Treasury Shares fell 81.25% to $3000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $3000.0 through Dec 2022, down 81.25% year-over-year, with the annual reading at $3000.0 for FY2022, 81.25% down from the prior year.
  • Treasury Shares hit $3000.0 in Q4 2022 for Serina Therapeutics, down from $6000.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $50000.0 in Q4 2019 to a low of $3000.0 in Q4 2022.
  • Historically, Treasury Shares has averaged $20181.8 across 4 years, with a median of $19000.0 in 2021.
  • Biggest five-year swings in Treasury Shares: crashed 38.71% in 2021 and later crashed 81.25% in 2022.
  • Year by year, Treasury Shares stood at $50000.0 in 2019, then crashed by 44.0% to $28000.0 in 2020, then plummeted by 42.86% to $16000.0 in 2021, then plummeted by 81.25% to $3000.0 in 2022.
  • Business Quant data shows Treasury Shares for SER at $3000.0 in Q4 2022, $6000.0 in Q3 2022, and $9000.0 in Q2 2022.